National COVID Cancer Survey

Many individuals living with cancer have good protection from COVID-19. However, some people have a less effective immune response and have lower antibody levels.

The National COVID Cancer Survey will evaluate finger prick COVID antibody testing in 10,000 individuals with cancer.

If you live in England, have been diagnosed with cancer in the last year, or on anti-cancer treatment, you can enrol directly to participate.

COVID antibody testing will be available through the NHS Test and Trace home antibody program.

Research from the survey will improve understanding of the protection provided by antibodies generated following COVID-19 infection and vaccination. It will also aid wider efforts to safeguard, protect and monitor vulnerable groups.